These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 31887543)

  • 1. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV Mediates the PI3K/Akt/mTOR Pathway to Alleviate Injury and Modulate the Composition of Intestinal Flora in ApoE
    Sun D; Wang Y; Pang B; Jiang L
    Discov Med; 2024 May; 36(184):1070-1079. PubMed ID: 38798265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
    Zhuang J; Peng W; Li H; Lu Y; Wang K; Fan F; Li S; Xu Y
    PLoS One; 2013; 8(12):e82509. PubMed ID: 24349299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
    Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
    J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA protects mice against atherosclerotic injury by activating the TGF-β/PI3K/Akt/eNOS pathway.
    Wang J; He X; Chen W; Zhang N; Guo J; Liu J; Zhang L; Sun H; Jia L; Yang G
    Coron Artery Dis; 2020 Jun; 31(4):385-392. PubMed ID: 31842027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
    Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
    J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway.
    Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ
    Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
    Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
    Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
    Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
    Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.
    Zhao D; Tong L; Zhang L; Li H; Wan Y; Zhang T
    Mol Med Rep; 2016 Dec; 14(6):4983-4990. PubMed ID: 27840935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-κB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice.
    Feng X; Du M; Li S; Zhang Y; Ding J; Wang J; Wang Y; Liu P
    Phytomedicine; 2023 Apr; 112():154684. PubMed ID: 36738477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of Non-POU-domain-containing octamer-binding protein stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice via NF-κB signaling pathway.
    Zhang K; Zhang F; Yang JM; Kong J; Meng X; Zhang M; Zhang C; Zhang Y
    Int J Cardiol; 2018 Jul; 263():96-103. PubMed ID: 29673854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA and Astragaloside IV Inhibit miR-223/JAK2/STAT1 Signalling Pathway to Alleviate Lipopolysaccharide-Induced Damage in Nucleus Pulposus Cells.
    Du X; Wang X; Cui K; Chen Y; Zhang C; Yao K; Hao Y; Chen Y
    Dis Markers; 2021; 2021():6554480. PubMed ID: 34676010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
    Hao D; Danbin W; Maojuan G; Chun S; Bin L; Lin Y; Yingxin S; Guanwei F; Yefei C; Qing G; Xijuan J
    Pharmacol Res; 2019 Aug; 146():104306. PubMed ID: 31181336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially
    Chen Z; Gao X; Jiao Y; Qiu Y; Wang A; Yu M; Che F; Li S; Liu J; Li J; Zhang H; Yu C; Li G; Gao Y; Pan L; Sun W; Guo J; Cao B; Zhu Y; Xu H
    Front Pharmacol; 2019; 10():850. PubMed ID: 31402870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 55.